Kuangli Bio-Tech Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Kuangli Bio-Tech Holdings has a total shareholder equity of NT$605.5M and total debt of NT$202.0M, which brings its debt-to-equity ratio to 33.4%. Its total assets and total liabilities are NT$1.1B and NT$495.9M respectively.
Key information
33.4%
Debt to equity ratio
NT$202.01m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$112.20m |
| Equity | NT$605.47m |
| Total liabilities | NT$495.89m |
| Total assets | NT$1.10b |
Recent financial health updates
We're Not Worried About Kuangli Photoelectric Technology's (TPE:6431) Cash Burn
Mar 31
We Think Kuangli Photoelectric Technology (TPE:6431) Can Easily Afford To Drive Business Growth
Dec 09
Recent updates
Kuangli Bio-Tech Holdings Co., Ltd.'s (TWSE:6431) Shareholders Might Be Looking For Exit
Mar 22We're Not Worried About Kuangli Photoelectric Technology's (TPE:6431) Cash Burn
Mar 31Did Business Growth Power Kuangli Photoelectric Technology's (TPE:6431) Share Price Gain of 248%?
Feb 03We Think Kuangli Photoelectric Technology (TPE:6431) Can Easily Afford To Drive Business Growth
Dec 09Financial Position Analysis
Short Term Liabilities: 6431's short term assets (NT$347.2M) exceed its short term liabilities (NT$298.3M).
Long Term Liabilities: 6431's short term assets (NT$347.2M) exceed its long term liabilities (NT$197.6M).
Debt to Equity History and Analysis
Debt Level: 6431's net debt to equity ratio (14.8%) is considered satisfactory.
Reducing Debt: 6431's debt to equity ratio has increased from 0% to 33.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6431 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6431 has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 2.8% each year.